Jeffrey Weinberger, MD
Vascular Surgery · Indianapolis, INNPI 1164637070
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $15,505 of the $20,146 with a category attached, or 77.0%. 36 manufacturers reported payments, led by W. L. Gore & Associates, Inc. at 27.9% of the total.
Across 360 payments — averaging $55.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- W. L. Gore & Associates, Inc.$6K
- Boston Scientific$3K
- Heraeus Medical Components, LLC$2K
- Johnson & Johnson$1K
- Silk Road Medical, Inc.$1K
- Endologix LLC$1K
- plus $7K from 30 others
What the payments were for
- Consulting fees$2,10010%
- Travel & lodging$2,53113%
- Food & beverage$15,50577%
- Education$100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| W. L. Gore & Associates, Inc. | 74 | $5,627 |
| Boston Scientific | 33 | $2,741 |
| Heraeus Medical Components, LLC | 2 | $1,800 |
| Johnson & Johnson | 49 | $1,281 |
| Silk Road Medical, Inc. | 10 | $1,057 |
| Endologix LLC | 15 | $1,026 |
| Cook Medical LLC | 23 | $1,007 |
| Reflow Medical Inc | 8 | $883 |
| Abbott | 9 | $815 |
| Philips North America LLC | 6 | $634 |
| Bolton Medical Inc | 8 | $373 |
| E.r. Squibb & Sons, L.L.C. | 23 | $350 |
| Edwards Lifesciences | 10 | $318 |
| Penumbra, Inc. | 3 | $302 |
| Tactile Systems Technology Inc | 10 | $209 |
| Stryker | 3 | $176 |
| Terumo Medical Corporation | 2 | $172 |
| Pfizer | 11 | $171 |
| Inari Medical, Inc. | 5 | $167 |
| Boehringer Ingelheim | 8 | $133 |
| EKOS Corporation | 4 | $114 |
| AstraZeneca | 7 | $107 |
| Bayer | 5 | $97 |
| Amgen | 5 | $92 |
| Regeneron Healthcare Solutions, Inc. | 6 | $78 |
| Cardiovascular Systems Inc. | 4 | $63 |
| Lemaitre Vascular, Inc. | 2 | $61 |
| Medtronic(2 entities) | 3 | $60 |
| Shockwave Medical, Inc | 2 | $54 |
| Amarin Pharma, Inc. | 2 | $38 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $35 |
| Lexicon Pharmaceuticals, Inc. | 2 | $31 |
| Novartis | 1 | $21 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $18 |
| Livanova USA, Inc. | 1 | $17 |
| Novo Nordisk | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENROUTE Transcarotid Neuroprotection System$2,509
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$1,197
- GORE TAG Thoracic Endoprosthesis$1,133
- ENROUTE Transcarotid Stent$997
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$723
- GENERAL VASCULAR INTERVENTION$621
- Technical Education MRI$327
- XARELTO$300
- ENDOCROSS Device$265
- Torus Stent Graft System$265
- Alto Abdominal Stent Graft System$262
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$192
- Zenith Spiral-Z$190
- Diamondback Peripheral$167
- EKOSONIC$163
- Zenith$159
- GORE PROPATEN Vascular Graft$150
- Indigo System$149
- GORE EXCLUDER AAA Endoprosthesis$149
- Azur CX Detachable$149
How this compares
$20,146 in reported general payments places this provider in the 85th percentile of 71 vascular surgery providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 83 | $82,203 |
| EliquisApixaban | 58 | $51,872 |
| ClopidogrelClopidogrel Bisulfate | 157 | $1,475 |
| Cilostazol | 53 | $1,264 |
| Atorvastatin Calcium | 101 | $598 |
| Pentoxifylline | 13 | $270 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 43 | $238 |
| Gabapentin | 11 | $218 |
| Mupirocin | 18 | $113 |
| Prednisone | 14 | $24 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $1,281 | $82,20383 claims |
| PfizerEliquis | $171 | $51,87258 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 71 vascular surgery providers in Indiana.
Other vascular surgery in Indianapolis
- Sajjad HussainIndianapolis$109K
- Andres FajardoIndianapolis$58K
- Brandon DowningIndianapolis$33K
- Deepak GuttikondaIndianapolis$33K
- Sarah StrotIndianapolis$15K
- Randy IrwinIndianapolis$14K
- Mary ZornIndianapolis$12K
- Charles KiellIndianapolis$10K
- Hanaa Dakour AridiIndianapolis$8K
- Richard OfsteinIndianapolis$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.